Your browser doesn't support javascript.
loading
High local failure rates despite high margin-negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi-agent chemotherapy.
Hill, Colin; Sehgal, Shuchi; Fu, Wei; Hu, Chen; Reddy, Abhinav; Thompson, Elizabeth; Hacker-Prietz, Amy; Le, Dung; De Jesus-Acosta, Ana; Lee, Valerie; Zheng, Lei; Laheru, Daniel A; Burns, William; Weiss, Matthew; Wolfgang, Christopher; He, Jin; Herman, Joseph M; Meyer, Jeffrey; Narang, Amol.
Affiliation
  • Hill C; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Sehgal S; Philadelphia College of Osteopathic Medicine, Philadelphia, Pennsylvania, USA.
  • Fu W; Department of Biostatistics and Bioinformatics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Hu C; Department of Biostatistics and Bioinformatics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Reddy A; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Thompson E; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Hacker-Prietz A; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Le D; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • De Jesus-Acosta A; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Lee V; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Zheng L; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Laheru DA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Burns W; Department of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center, Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland, USA.
  • Weiss M; Department of Surgery, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Wolfgang C; Department of Surgery, Zucker School of Medicine at Hofstra/Northwell, Lake Success, New York, USA.
  • He J; Department of Medical Oncology, The Sidney Kimmel Comprehensive Cancer Center, Bloomberg-Kimmel Institute for Cancer Immunotherapy at Johns Hopkins, Baltimore, Maryland, USA.
  • Herman JM; Department of Surgery, New York University Grossman School of Medicine, New York, New York, USA.
  • Meyer J; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
  • Narang A; Department of Radiation Oncology and Molecular Radiation Sciences, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Cancer Med ; 11(7): 1659-1668, 2022 04.
Article in En | MEDLINE | ID: mdl-35142085

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Radiosurgery Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2022 Type: Article Affiliation country: United States

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Radiosurgery Type of study: Observational_studies / Risk_factors_studies Limits: Humans Language: En Journal: Cancer Med Year: 2022 Type: Article Affiliation country: United States